Clinical Trials

11 enrolled 12 charts

Leukemia, Leukemia, Myeloid, Acute

NCT04687098 2023-06-27

Risk-adapted Therapy for Primary Acute Myeloid Leukemia

1,034 enrolled

Leukemia, Leukemia, Myeloid, Acute

NCT00840177 2023-05-03

S0919 Idarubicin, Cytarabine, and Pravastatin in Treating Patients With Relapsed Acute Myeloid Leukemia

115 enrolled 12 charts

Congenital Abnormalities, Leukemia, Leukemia, Myeloid, Acute

NCT00003405 2021-10-14

Combination Chemotherapy Plus Biological Therapy in Treating Patients With Acute Myelogenous Leukemia

Phase 2 Withdrawn

MyeloidOther hematologic neoplasm

Leukemia, Erythroblastic, Acute, Leukemia, Leukemia, Megakaryoblastic, Acute, Leukemia, Monocytic, Acute, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Acute

NCT00004878 2020-07-31

Donor Lymphocytes to Prevent Graft-Versus-Host Disease in Patients With Chronic Myeloid Leukemia

Phase 2 Withdrawn

Graft vs Host Disease, Leukemia, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase

NCT00458848 2019-02-15

LAL0904

470 enrolled 10 charts

Leukemia, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT01025154 2018-10-09

Clofarabine, Idarubicin, and Cytarabine Combination in Acute Myeloid Leukemia (AML) Induction

63 enrolled 6 charts

Leukemia, Leukemia, Myeloid, Acute

NCT00422591 2018-08-23

Standard Idarubicin and Cytarabine for the Treatment of Acute Myeloid Leukemia (AML)

175 enrolled 9 charts

Leukemia, Leukemia, Myeloid, Acute

NCT01692197 2018-07-03

E7070, Idarubicin and Cytarabine in Relapsed AML and High-Risk Myelodysplastic Syndromes

43 enrolled 11 charts

Leukemia, Recurrence, Leukemia, Myeloid, Acute

NCT00528398 2017-02-06

Idarubicin and High-Dose Cytarabine in Treating Patients With Acute Myeloid Leukemia

111 enrolled 7 charts

Congenital Abnormalities, Leukemia, Erythroblastic, Acute, Leukemia, Leukemia, Megakaryoblastic, Acute, Leukemia, Monocytic, Acute, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Acute

NCT00528450 2016-01-29

Tretinoin and Arsenic Trioxide With or Without Idarubicin in Treating Patients With Acute Promyelocytic Leukemia

Phase 2 Terminated

1 enrolled 4 charts

Leukemia, Leukemia, Promyelocytic, Acute

NCT01700413 2016-01-28

Efficacy and Toxicity of Increasing Doses of Idarubicin, Cytarabine and G-CSF in Acute Myeloid Leukemia

48 enrolled

Leukemia

NCT00656617 2015-03-09

Phase II Study of Idarubicin, Cytarabine, and Vorinostat With High-Risk Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML)

MyeloidOther hematologic neoplasm

106 enrolled 6 charts

Leukemia, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT00003783 2014-07-28

Combination Chemotherapy in Treating Children With Very High Risk Acute Lymphocytic Leukemia

36 enrolled

Leukemia, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00003178 2014-07-25

Chemotherapy in Treating Children With Recurrent Acute Myeloid Leukemia

120 enrolled

Leukemia

NCT00002532 2013-08-07

Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphocytic Leukemia

Phase 2 Unknown

Leukemia, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00002800 2013-07-03

Chemotherapy in Treating Patients With Newly Diagnosed Acute or Chronic Myelogenous Leukemia or Myelodysplastic Syndrome

Classical hematologyMyeloidOther hematologic neoplasm

60 enrolled

Anemia, Refractory, with Excess of Blasts, Blast Crisis, Leukemia, Myelodysplastic Syndromes, Neutropenia, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myelomonocytic, Chronic

NCT00002609 2013-06-24

Monoclonal Antibody Therapy and Chemotherapy in Treating Patients With Acute Promyelocytic Leukemia in Remission

40 enrolled

Leukemia, Leukemia, Promyelocytic, Acute

NCT00004905 2013-05-30

Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous Leukemia or Acute Leukemia

Leukemia, Leukemia, Myeloid, Chronic-Phase, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00016159 2013-01-16

Chemotherapy Plus Monoclonal Antibody in Treating Patients With Acute Promyelocytic Leukemia

35 enrolled

Leukemia, Leukemia, Promyelocytic, Acute

NCT00003729 2012-09-24

Combination Chemotherapy in Treating Children With Relapsed or Refractory Acute Lymphocytic Leukemia

Phase 2 Terminated

13 enrolled

Leukemia, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00002833 2012-07-30

Peripheral Stem Cell Transplantation Plus Filgrastim in Treating Patients With Acute or Chronic Myelogenous Leukemia

Classical hematologyMyeloidOther hematologic neoplasm

53 enrolled

Anemia, Refractory, with Excess of Blasts, Blast Crisis, Graft vs Host Disease, Leukemia, Myelodysplastic Syndromes, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic

NCT00006122 2012-07-16

Gemtuzumab Ozogamicin With or Without Chemotherapy in Treating Older Patients With Acute Myeloid Leukemia

106 enrolled

Leukemia, Erythroblastic, Acute, Leukemia, Leukemia, Megakaryoblastic, Acute, Leukemia, Monocytic, Acute, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Acute

NCT00077116 2012-07-16

Idarubicin, Cytarabine, and Gemtuzumab Ozogamicin in Treating Patients With Previously Untreated High-Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia Secondary to Myelodysplastic Syndrome

Classical hematologyMyeloidOther hematologic neoplasm

31 enrolled

Congenital Abnormalities, Anemia, Refractory, with Excess of Blasts, Leukemia, Myelodysplastic Syndromes, Leukemia, Myelomonocytic, Chronic

NCT00003758 2009-02-09

Combination Chemotherapy in Treating Patients With Relapsed Acute Myelogenous Leukemia

Phase 2 Unknown

60 enrolled